Innovating Works

DESENTUM OY

Desconocido
AllergyVAX: Next generation allergen immunotherapy based on specifically modified recombinant hypoallergens DESENTUM OY tramitó un H2020 H2020-EIC-SMEInst-2018-2020 Allergy is a rapidly increasing, global problem that already affects 1 billion people and causes significant social and economic burden. In...
2018-10-25 - 2021-07-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.